Treatment review and update for myasthenia gravis

Gil I. Wolfe, Bella Gross

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Myasthenia gravis (MG) is the best understood autoimmune disease, with well-characterized humoral and cellular effector mechanisms. It is not surprising, therefore, that immunotherapies play a key role in the management of MG. Significant progress has been made over the last few decades in the treatment of patients with MG, and the number of effective avenues of therapy continue to increase. In this review, we provide an update on management options in MG, highlighting recent literature on both traditional and more novel approaches.

Original languageEnglish
Pages (from-to)54-68
Number of pages15
JournalJournal of Clinical Neuromuscular Disease
Issue number2
StatePublished - Dec 2004
Externally publishedYes


  • Immunosuppression
  • Myasthenia gravis
  • Thymectomy
  • Treatment


Dive into the research topics of 'Treatment review and update for myasthenia gravis'. Together they form a unique fingerprint.

Cite this